Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of crovalimab versus eculizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria
CTR20210827Phase 3Active
- Sponsor
- Roche
- Start
- Jul 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of crovalimab in paroxysmal nocturnal hemoglobinuria (PNH), sponsored by Roche. Started Jul 2021; status: active.
02
Drugs
crovalimab
03
Conditions
paroxysmal nocturnal hemoglobinuria (PNH)
Beyond the preview
Go deeper on CTR20210827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210827.